Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
198.90    -3.70 (-1.83%)
Bid:
198.80
Ask:
199.40
Spread: 0.60 (0.302%)
Market Cap: £1.29b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

14 Jul 2017 07:00

RNS Number : 0496L
Ashmore Group PLC
14 July 2017
 

 Ashmore Group plc

+0700 14 July 2017

FOURTH QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 30 June 2017.

Assets under management

Theme

Actual31 March 2017

(US$ billion)

Estimated30 June 2017

(US$ billion)

Movement

Q4 vs Q3

(%)

External debt

12.9

13.3

+3%

Local currency

13.5

13.7

+1%

Corporate debt

5.5

6.3

+15%

Blended debt

13.6

14.6

+7%

Equities

3.1

3.4

+10%

Alternatives

1.4

1.5

+7%

Multi-asset

1.1

1.1

-

Overlay / liquidity

4.8

4.8

-

Total

55.9

58.7

+5%

 

Assets under management increased by US$2.8 billion during the period, comprising positive investment performance of US$1.6 billion and net inflows of US$1.2 billion.

Momentum in gross sales continued across the product range in the quarter and gross redemptions reduced again quarter-on-quarter. Subscriptions were from a diverse range of client types, and included both new mandates and additional allocations from existing clients. Net inflows were delivered in blended debt, corporate debt, equities and alternatives, while flows were flat in external debt, multi-asset and overlay/liquidity. Local currency experienced a net outflow as a consequence of a large institutional account redemption.

Emerging Markets assets continued to deliver good absolute returns during the quarter and outperformed developed world fixed income and equity markets. Ashmore's investment processes generated positive investment performance across its fixed income and equities investment themes, with particularly strong performance in local currency followed by external debt. Performance was flat in multi-asset, alternatives and overlay/liquidity. The Group's investment track record relative to benchmarks remains strong over one, three and five years.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Ashmore has performed well over the past 12 months, delivering a 12% increase in AuM through strong investment performance and net inflows in the past two quarters. Emerging Markets asset prices have started to reflect the resilient fundamentals of the underlying economies and investor activity levels are responding. Looking ahead, there is substantial absolute and relative value still available in Emerging Markets and investor allocations have much further to run from their significantly underweight levels."

 

Notes

1. For the translation of US dollar-denominated balance sheet items, the GBP/USD exchange rate was 1.2946 at 30 June 2017 (30 June 2016: 1.3234; 31 December 2016: 1.2340). For the translation of US dollar management fees, the average GBP/USD exchange rate achieved for the financial year was 1.2766 (FY2015/16: 1.4759).

Ashmore will announce its financial results in respect of the year ended 30 June 2017 on 7 September 2017.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingAndrew Walton +44 (0)20 3727 1514Kit Dunford +44 (0)20 3727 1143

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFERDSIVLID
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.